Serge Van Calenbergh graduated in pharmaceutical sciences in 1991 at the UGent and obtained his PhD from the same institution in 1995 with Prof. Piet Herdewijn. He spent the first year of his doctoral training at the Laboratory for Medicinal Chemistry of the REGA Institute in Leuven. In 1996-1997 he was a NIH-funded post-doctoral fellow at the Department of Chemistry of the University of Iowa in Iowa City with Prof. Vasu Nair. In October 1999 he became professor and from 2018 full Professor in Medicinal Chemistry at the Faculty of Pharmaceutical Sciences of the UGent. His main research interests include the development of small molecules for neglected diseases such as TB and malaria and synthetic work on nucleoside analogue and on glycolipid analogues as iNKT-cell agonists. He has leading roles in scientific societies such as member of the European Federation for Medicinal Chemistry (EFMC) and member International Advisory Boards of ChemMedChem and Eur. J. Org. Chem.